Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Mol Biol ; 56(5): 649-667, 2022.
Article in English | MEDLINE | ID: mdl-36217336

ABSTRACT

Viruses are now recognized as bona fide etiologic factors of human cancer. Carcinogenic viruses include Epstein- Barr virus (EBV), high-risk human papillomaviruses (HPVs), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus type 1 (HTLV-1), human immunodeficiency virus type 1 (HIV-1, indirectly), and several candidate human cancer viruses. It is estimated that 15% of all human tumors worldwide are caused by viruses. Tumor viruses establish long-term persistent infections in humans, and cancer is an accidental side effect of viral replication strategies. Viruses are usually not complete carcinogens, supporting the concept that cancer results from the accumulation of multiple cooperating events, in which human cancer viruses display different, often opposing roles. The laboratory mouse Mus musculus is one of the best in vivo experimental systems for modeling human pathology, including viral infections and cancer. However, mice are unsusceptible to infection with the known carcinogenic viruses. Many murine models were developed to overcome this limitation and to address various aspects of virus-associated carcinogenesis, from tumors resulting from xenografts of human tissues and cells, including cancerous and virus infected, to genetically engineered mice susceptible to viral infections and associated cancer. The review considers the main existing models, analyzes their advantages and drawbacks, describes their applications, outlines the prospects of their further development.

2.
Mol Biol (Mosk) ; 56(5): 710-731, 2022.
Article in Russian | MEDLINE | ID: mdl-36165012

ABSTRACT

Viruses are now recognized as bona fide etiologic factors of human cancer. Carcinogenic viruses include Epstein-Barr virus (EBV), high-risk human papillomaviruses (HPVs), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus type 1 (HTLV-1), human immunodeficiency virus type 1 (HIV-1, indirectly), and several candidate human cancer viruses. It is estimated that 15% of all human tumors worldwide are caused by viruses. Tumor viruses establish long-term persistent infections in humans, and cancer is an accidental side effect of viral replication strategies. Viruses are usually not complete carcinogens, supporting the concept that cancer results from the accumulation of multiple cooperating events, in which human cancer viruses display different, often opposing roles. The laboratory mouse Mus musculus is one of the best in vivo experimental systems for modeling human pathology, including viral infections and cancer. However, mice are unsusceptible to infection with the known carcinogenic viruses. Many murine models were developed to overcome this limitation and to address various aspects of virus-associated carcinogenesis, from tumors resulting from xenografts of human tissues and cells, including cancerous and virus infected, to genetically engineered mice susceptible to viral infections and associated cancer. The review considers the main existing models, analyzes their advantages and drawbacks, describes their applications, outlines the prospects of their further development.


Subject(s)
Epstein-Barr Virus Infections , HIV-1 , Neoplasms , Virus Diseases , Animals , Carcinogenesis , Carcinogens/toxicity , Disease Models, Animal , Herpesvirus 4, Human/genetics , Humans , Mice , Neoplasms/genetics , Virus Diseases/genetics
3.
Mol Biol (Mosk) ; 56(5): 795-807, 2022.
Article in Russian | MEDLINE | ID: mdl-36165018

ABSTRACT

Changes in metabolic pathways are often associated with the development of a wide range of pathologies. Increased glycolysis under conditions of sufficient tissue oxygen supply and its dissociation from the Krebs cycle, known as aerobic glycolysis or the Warburg effect, is a hallmark of many malignant neoplasms. Identification of specific metabolic shifts can characterize the metabolic programming of individual types of tumor cells, the stage of their transformation, and predict their metastatic potential. Viral infection can also alter the metabolism of cells to support the process of viral replication. Infection with human immunodeficiency virus type 1 (HIV-1) is associated with an increased incidence of various cancers, and for some viral proteins a direct oncogenic effect was demonstrated. In particular, we showed that the expression of HIV-1 reverse transcriptase (RT) in 4T1 breast adenocarcinoma cells increases the tumorigenic and metastatic potential of cells in vitro and in vivo by a mechanism associated with the ability of RT to induce reactive oxygen species in cells (ROS). The aim of this work was to study the molecular mechanism of this process, namely the effect of HIV-1 RT on the key metabolic pathways associated with tumor progression: glycolysis and mitochondrial respiration. Expression of HIV-1 RT had no effect on the glycolysis process. At the same time, it led to an increase in mitochondrial respiration and the level of ATP synthesis in the cell, while not affecting the availability of the substrates, carbon donors for the Krebs cycle, which excludes the effect of RT on the metabolic enzymes of cells. Increased mitochondrial respiration was associated with restoration of the mitochondrial network despite the RT-induced reduction in mitochondrial mass. Increased mitochondrial respiration may increase cell motility, which explains their increased tumorigenicity and metastatic potential. These data are important for understanding the pathogenesis of HIV-1 infection, including the stimulation of the formation and spread of HIV-1 associated malignancies.


Subject(s)
Breast Neoplasms , Carcinogenesis , HIV Reverse Transcriptase , HIV-1 , Mitochondria , Adenosine Triphosphate/biosynthesis , Animals , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Breast Neoplasms/virology , Carbon/metabolism , Carcinogenesis/genetics , Cell Line, Tumor , Cell Respiration , Citric Acid Cycle , Female , HIV Reverse Transcriptase/genetics , HIV-1/genetics , HIV-1/metabolism , Mice , Mitochondria/metabolism , Oxygen/metabolism , Reactive Oxygen Species/metabolism
4.
Clin Exp Allergy ; 43(6): 625-32, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23711124

ABSTRACT

BACKGROUND: Enterovirus infections in childhood have been associated with a reduced risk of atopy in cross-sectional studies. OBJECTIVE: To study the relation between enterovirus infections in the first 2 years of life and atopic disease with IgE sensitization in a prospective study setting. METHODS: This was a nested case-control study among children who had been followed from birth. Neutralizing antibodies against 12 enterovirus serotypes were analysed at the age of 2 years from 71 atopic children and 142 non-atopic control children. Atopy was defined as having an atopic disease and IgE antibodies against at least one aeroallergen by the age of 5 years. RESULTS: Cumulative exposure to different enterovirus serotypes was inversely associated with atopy [odds ratio (OR) 0.73; 95% confidence interval (CI): 0.56-0.96]. The most pronounced protection was seen when echoviruses were analysed as a separate group (OR 0.63; 95%CI: 0.46-0.88). CONCLUSIONS AND CLINICAL RELEVANCE: We propose that exposure to several different enteroviruses in early childhood is inversely associated with atopic diseases. Our results support the hypothesis that repeated microbial infections in early life may protect from atopic sensitization and atopic diseases.


Subject(s)
Enterovirus Infections/complications , Hypersensitivity, Immediate/etiology , Age Factors , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Case-Control Studies , Child, Preschool , Enterovirus/classification , Enterovirus/immunology , Enterovirus Infections/immunology , Follow-Up Studies , Humans , Hypersensitivity, Immediate/epidemiology , Infant , Infant, Newborn , Risk , Seroepidemiologic Studies
5.
Clin Exp Allergy ; 38(12): 1929-34, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19037967

ABSTRACT

BACKGROUND: Total serum IgE is regulated by both environmental and genetic factors. Association and linkage studies have suggested a role of CD14-159C>T polymorphism in the regulation of serum total IgE, but the results have been contradictory. It seems that gene-environment interactions are involved in this regulation. OBJECTIVE: The aim of this study was to examine the possible gene-environment interactions among Toxoplasma gondii, Helicobacter pylori, CD14-159C>T and Toll-like receptor (TLR) 4+896A>G polymorphism on serum total IgE. For this study, we expanded the scope of our earlier comparison of allergic sensitization and microbial load between Finland and Russian Karelia by studying the CD14-159C>T and TLR4+896A>G polymorphism in a cohort of Russian Karelian children. METHODS: For this study, CD14-159C>T and TLR4+896A>G polymorphisms were analysed in 264 healthy Russian Karelian children. Serum total IgE levels and H. pylori and T. gondii antibodies were also measured. RESULTS: We constructed a multiway anova model to analyse the gene-environment interactions among T. gondii seropositivity, H. pylori seropositivity, CD14-159C>T and TLR4+896A>G polymorphisms on serum total IgE. The model showed that there was an interaction between the CD14-159 allele T carrier status and H. pylori antibodies on serum total IgE (P=0.004). No other interactions were found. CONCLUSION: Our results further emphasize the role of gene-environment interaction in the regulation of serum total IgE.


Subject(s)
Carrier State/immunology , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Immunoglobulin E/blood , Lipopolysaccharide Receptors/genetics , Toll-Like Receptor 4/genetics , Adolescent , Alleles , Amino Acid Substitution , Animals , Antibodies, Bacterial/blood , Child , Female , Helicobacter Infections/blood , Humans , Immunoglobulin E/genetics , Male , Polymorphism, Single Nucleotide , Toxoplasmosis/blood , Toxoplasmosis/genetics
6.
Clin Exp Immunol ; 148(1): 47-52, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17302731

ABSTRACT

Epidemiological data have indicated that some infections are associated with a low risk of allergic diseases, thus supporting the idea (hygiene hypothesis) that the microbial load is an important environmental factor conferring protection against the development of allergies. We set out to test the hygiene hypothesis in a unique epidemiological setting in two socio-economically and culturally markedly different, although genetically related, populations living in geographically adjacent areas. The study cohorts included 266 schoolchildren from the Karelian Republic in Russia and 266 schoolchildren from Finland. The levels of total IgE and allergen-specific IgE for birch, cat and egg albumen were measured. Microbial antibodies were analysed against enteroviruses (coxsackievirus B4), hepatitis A virus, Helicobacter pylori and Toxoplasma gondii. Although total IgE level was higher in Russian Karelian children compared to their Finnish peers, the prevalence of allergen-specific IgE was lower among Russian Karelian children. The prevalence of microbial antibodies was, in turn, significantly more frequent in the Karelian children, reflecting the conspicuous difference in socio-economic background factors. Microbial infections were associated with lower risk of allergic sensitization in Russian Karelian children, enterovirus showing the strongest protective effect in a multivariate model. The present findings support the idea that exposure to certain infections, particularly in childhood, may protect from the development of atopy. Enterovirus infections represent a new candidate to the list of markers of such a protective environment. However, possible causal relationship needs to be confirmed in further studies.


Subject(s)
Bacteria/isolation & purification , Hypersensitivity/microbiology , Viruses/isolation & purification , Adolescent , Allergens/immunology , Animals , Antibodies, Bacterial/blood , Antibodies, Protozoan/blood , Antibodies, Viral/blood , Betula/immunology , Cats/immunology , Child , Enterovirus B, Human/immunology , Enterovirus B, Human/isolation & purification , Female , Finland/epidemiology , Helicobacter pylori/immunology , Helicobacter pylori/isolation & purification , Hepatitis A virus/immunology , Hepatitis A virus/isolation & purification , Humans , Hypersensitivity/ethnology , Hypersensitivity/immunology , Immunoglobulin E/blood , Male , Ovalbumin/immunology , Pollen/immunology , Russia/epidemiology , Toxoplasma/immunology , Toxoplasma/isolation & purification
7.
Diabetologia ; 48(7): 1280-7, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15902401

ABSTRACT

AIMS/HYPOTHESIS: We have previously observed an inverse correlation between the incidence of type 1 diabetes and enterovirus infections in the background population. The aim of this study was to analyse whether maternal enterovirus antibody status, which reflects both the frequency of enterovirus infections and the protection conferred by the mother on the offspring, also correlates with the incidence of type 1 diabetes. METHODS: Maternal enterovirus antibodies were analysed from serum samples taken from pregnant women between 1983 and 2001 in Finland and Sweden using enzyme immunoassay and neutralisation assays. Comparable samples were also taken between 1999 and 2001 in countries with a lower incidence of diabetes (Estonia, Germany, Hungary, Israel, Lithuania, Russia). RESULTS: A clear decrease was observed in maternal enterovirus antibody levels over the past 20 years (p<0.0001). The frequency of enterovirus antibodies was higher in countries with a low or intermediate incidence of type 1 diabetes compared with high-incidence countries (p<0.0001). CONCLUSIONS/INTERPRETATION: These findings are in line with our previous observations supporting the hypothesis that a low frequency of enterovirus infection in the background population increases the susceptibility of young children to the diabetogenic effect of enteroviruses.


Subject(s)
Antibodies, Viral/blood , Diabetes Mellitus, Type 1/epidemiology , Enterovirus/immunology , Female , Finland/epidemiology , Geography , Humans , Immunoglobulin G/blood , Incidence , Neutralization Tests , Pregnancy , Sweden/epidemiology , Viral Plaque Assay
SELECTION OF CITATIONS
SEARCH DETAIL
...